rmc-6236
revolution medicines
['pancreatic', 'rmc-6236']
early clinical data on revolution med s multi-ras inhibitor (rmc-6236). remarkably shutting off all (or almost all) ras isoforms in the body does not result in major deleterious effects in patients. also 1st glimpses of monotherapy responses (including #pancreaticcancer) #aacr23 
Pancreatic cancer researcher and GI pathologist. Striving to improve the lives of patients with cancer. May or may not be notable.